Aktualisierungen der europäischen Leitlinien zur Herzinsuffizienz: Eine Peer-to-Peer-Diskussion über SGLT-2-Hemmer

Published: 14 September 2021

  • Views:

    Views Icon 1523
  • Likes:

    Heart Icon 2

Overview

Full programme

Overview

In diesem Peer-to-Peer-Video zu den kommenden Herzinsuffizienz-Leitlinien geben uns Prof. Böhm, Prof. Hassenfuß und Prof. Anker eine lokale Interpretation. Zunächst werfen wir einen Blick auf die Richtlinien von 2016 und betrachten dann die Anpassungen der ESC-Herzinsuffizienz-Leitlinien von 2021 und was diese für die Verwendung von SGLT-2-Inhibitoren bei HFrEF bedeuten. Insbesondere betrachten wir die Entwicklung der neuen Leitlinien näher und überlegen, wie diese in der zukünftigen Praxisarbeit umgesetzt werden sollten.

 

Videofilmer: Mike Knight

Editor: Oliver Miles

Unterstützt von der Boehringer Ingelheim & Lilly Alliance

Series overview

Part 1

Woher kommen wir?

Part 2

Update zu den Empfehlungen der ESC-HF-Leitlinie 2021 für SGLT-2-Inhibitoren

Part 3

Untersuchung der klinischen Daten hinter Leitlinienaktualisierungen

Part 4

Praxis mit SGLT-2-Hemmern

Faculty Biographies

Gerd Hasenfuß

Gerd Hasenfuß

Professor of Internal Medicine, Director of the Department of Cardiology and Pulmonology

Prof Gerd Hasenfuß is a Professor of Internal Medicine, Director of the Department of Cardiology and Pulmonology, Georg-August-Universität Göttingen; Chairman of the Heart Center and the Herzforschungszentrum Göttingen; Head of Internal Medicine, Clinic and Rehabilitation Center Lippoldsberg gGmbH.

View full profile
Michael Böhm

Michael Böhm

Director Internal Medicine Clinic III, Angiology and Intensive Care Medicine

Dr Michael Böhm performed his medical training at the Medical School of Hannover in Germany. Residency in Internal Medicine and fellowships in Cardiology at the Ludwig Maximilians-Unversity in Munich/Germany at the Klinikum Großhadern; Heisenberg Graduate of the Deutsche Forschungsgemeinschaft; Assistant and Associate Dr of Internal Medicine and Cardiology at the Universität zu Köln in Germany.

Dr Böhm is Director of the Klinik für Innere Medizin III and Chief of Cardiology at the University of the Saarland in Homburg/Saar in Germany. Dr Böhm's special interest includes pathophysiology and therapy of heart failure. Particular, he is involved in studies on signal transduction in the failing heart and in vascular biology. Dr Böhm has been the principal investigator in several international multicenter studies. He has written more than 350 original papers, book chapters and review articles. He has obtained several awards of scientific societies. Dr Böhm is a reviewer for…

View full profile
Stefan Anker

Stefan Anker

Professor of Cardiology

Personal History

Dr Stefan Anker was born in East Berlin, Germany in 1965 and has been a doctor for almost thirty years. In his own words, he “never considered doing anything other than medicine.” He is a prodigious researcher who has published over 950 original papers, reviews and editorials. 

Dr Anker has also won a number of awards, including the 2018 Copernicus Prize from the German DFG and Polish FNP. Working with both systems in the United Kingdom and Germany has been enjoyable for him because he loves the freedom that it provides as an academic. He would like to play more tennis or golf if he had the time, and enjoys collecting sculptures; particularly anything “skinny or thin.”

Academic History

Dr Anker studied medicine at Charité Medical School of Humboldt-University Berlin, Germany from 1987 to 1993. He went on to complete his PhD at the N

View full profile